The COVID-19 pandemic presented unique challenges to the delivery of healthcare for
patients with allergic rhinitis (AR) following its disruption and impact on the healthcare …

Abstract 110 years after the classical study by Noon, numerous studies have confirmed the
efficacy of allergen immunotherapy. A variety of clinical endpoints have been used in these …

Efficacious, effective and efficient communication between healthcare professionals (HCP)
and patients is essential to achieve a successful therapeutic alliance. Telemedicine (TM) …

Coronavirus disease 2019 (COVID-19) is a highly contagious viral disease caused by
severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). It has various effects on …

Background When the coronavirus pandemic 2019 (COVID‐19) emerged, concerns were
also raised regarding the safety of allergen immunotherapy (AIT). The German Society for …

Introduction Adolescence is a critical stage of rapid biological, emotional and social change
and development. Adolescents and young adults (AYA) with asthma and allergies need to …

Pregnant individuals are at higher risk of complications from respiratory viruses such as
coronavirus-19 disease (COVID-19). Altered lung function, vaccine hesitancy, and …

Background The COVID-19 pandemic brought unprecedented global disruption to both
healthcare providers and patients with respiratory allergies. There are limited real-life data …

Introduction: Allergic diseases represent a broad spectrum of high-prevalence, chronic
conditions that remain underdiagnosed and undertreated. The aims of this interdisciplinary …

The COVID-19 pandemic posed an extraordinary challenge to societies and healthcare
systems. Allergic individuals could not be an exception, being both directly and indirectly …